WO2024141998 - METHOD OF TREATING TAUOPATHIES
National phase entry:
Publication Number
WO/2024/141998
Publication Date
04.07.2024
International Application No.
PCT/IB2023/063357
International Filing Date
28.12.2023
Title **
[English]
METHOD OF TREATING TAUOPATHIES
[French]
MÉTHODE DE TRAITEMENT DE TAUOPATHIES
Applicants **
GT GAIN THERAPEUTICS SA
Inventors
GARCÍA COLLAZO, Ana Maria
TRAPERO PUIG, Ana
CARRILLO ARREGUI, Jokin
CALVO-FLORES GUZMAN, Beatriz
Priority Data
22383316.1
30.12.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4208 | |
| EPO | Filing, Examination, Granting | 30973 | |
| Japan | Filing, Examination, Granting | 3297 | |
| South Korea | Filing, Examination, Granting | 4138 | |
| USA | Filing, Examination, Granting | 15240 |
Total:
57,856
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
are as set forth in the specification, in the treatment and/or prevention of disorders or diseases associated with hyperphosphorylation of tau protein, such as Pick's disease.[French]
sont tels que définis dans la description, dans le traitement et/ou la prévention de troubles ou de maladies associés à l'hyperphosphorylation de la protéine tau, telle que la maladie de Pick.